# XARELTO
> **NDA215859** · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2021-12-20
## Drug
- **FDA Application Number:** NDA215859
- **Application type:** New Drug Application
- **Brand name:** XARELTO
- **Generic name:** RIVAROXABAN
- **Active ingredients:** RIVAROXABAN
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** JANSSEN PHARMS
- **Manufacturer:** Janssen Pharmaceuticals, Inc.
- **First approval:** 2021-12-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215859)
---
*AI Analytics · CC0 1.0*